ZLZai Lab ZLAB · NASDAQ
$24.03 +9.03% (+$1.99)
- Market cap
- $2.46B
- Enterprise value
- $2.11B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 5.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -29.3%
- Bruto marža
- 56.5%
- Neto marža
- -41.9%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.83
- Free float
- 93.4%
O podjetju
Zai Lab Limited is a Chinese biotechnology company specializing in the development and commercialization of innovative drugs focused on the treatment of oncology and autoimmune diseases. The company concentrates on developing products in the fields of immunotherapy, targeted therapy, and other advanced treatment methods. Zai Lab collaborates with leading global pharmaceutical and biotechnology companies to bring the latest treatment options to the Chinese market and the broader Asia region, ensuring that patients have access to new therapies.
Sector
Healthcare
Industry
Biotechnology
CEO
Ying Du
Employees
1,784
Headquarters
Shanghai
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke